+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Diagnosis and Treatment of Rare Gynecologic Cancers

  • Book

  • August 2022
  • Elsevier Health Science
  • ID: 5483977
Offering a�one-stop guide to recognition and therapeutic decision making,�Diagnosis and Treatment of Rare Gynecologic Cancers�fills a gap in the medical literature on uncommon ovarian, uterine, cervical, and vulvovaginal cancers and trophoblastic diseases. This authoritative text, edited by Drs. Michael�Frumovitz, Mario�Leitao, and�Preetha�Ramalingam, has been authored by�internationally recognized experts from top institutions�such as MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center. Each chapter covers different cancer subtypes and has been�reviewed by an oncologist and a pathologist.
  • Provides�up-to-date clinical guidance�on assessment and therapeutic options for patients with rare gynecologic malignancies.�

  • Presents information in a�templated, easy-to-read format. Each chapter includes an introductory clinical case followed by epidemiology of disease, pathologic assessment, basic science/molecular/translational research, work-up of newly diagnosed disease, staging, treatment of newly diagnosed disease, treatment of recurrent disease, potential therapeutic targets, and a case resolution.�

  • Includes�diagnostic and treatment algorithms�for each form of cancer.�

  • Contains numerous anatomical figures, radiographs, photographs, and tables for�quick visual reference.�

  • Enhanced eBook version included with purchase.�Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.�

Table of Contents

Contributor Information: Please list names/affiliations of any contributors (can be tentative):

Section 1 - Ovarian Cancer

- Malignant Germ Cell Tumors

- Sex Cord-Stromal Tumors

- Malignant Mixed Mesodermal Tumor

- Clear Cell Carcinoma

- Mucinous Carcinomas

- Low-Grade Serous Tumors (MPSC) and Variants

- Small Cell (hypercalcemic)

- Other rare ovarian cancers (Small Cell Carcinoma (hypercalcemic), Small Cell Carcinoma (Neuroendocrine, Mesolthelioma, Squamous Cell, Sarcomas)

Section 2 - Uterine Cancer

- Leiomyosarcoma

- Other sarcomas of the uterus (Endometrial Stromal Sarcoma, STUMP, adenosarcoma)

- Carcinosarcoma

- Uterine Serous Carcinoma

- Other rare uterine cancers (Choriocarcinoma, Yolk Sac, Neuroendocrine)

Section 3 - Cervical Cancer

- High Grade Neuroendocrine Carcinoma

- Other rare cervical cancers (Verrucous Carcinoma, Clear Cell Carcinoma, Adenoid Cystic Carcinoma, Rhabdomyosarcoma)

Section 4 - Vulvovaginal Cancers

- Clear Cell Carcinoma

- Melanoma

- Bartholin Gland Carcinoma

- Benign and Malignant Paget's Disease

- Other rare vulvovaginal carcinomas (Verrucous Carcinoma, Embryonal Rhabdomyosarcoma, Yolk Sac Tumor, Aggressive Angiomyxoma, Sarcomas

Section 5 - Trophoblastic Disease

- Gestational Trophoblastic Disease and Placental Site Trophoblastic Tumor

Authors

Michael Frumovitz Professor, Gynecologic Oncology, MD Anderson Cancer Center. Mario M. Leitao Jr. Member and Fellowship Director, Gynecologic Oncology, Memorial Sloan Kettering Cancer Center, Professor, Weill Cornell Medical College.. Preetha Ramalingam Professor, Anatomic Pathology, MD Anderson Cancer Center. MD